9 March, 2020

The pharmaceutical industry warns of the risk of Europe becoming a non-driving, receiving market for innovation

The European employer of the innovative industry has its sights set on the roadmap of the Industrial Strategy for the sector, which will be published next […]
4 March, 2020

The pharmaceutical sector, the basis of a new production model in Spain

Source: www.expansion.com The pharmaceutical industry is positioned as a leading actor for the necessary evolution of the Spanish economy towards a productive model supported by innovation […]
24 February, 2020

Create the test that predicts the risk of infection in kidney transplants

Source: www.immedicohospitalario.es The clinical efficacy of this new diagnosed tool has been tested in five hospitals with clinical trials, which is a step towards personalized medicine […]
10 February, 2020

Drug R&D: increasingly high development costs and lower returns

The expected return on investment in new medicines stands at 1.8%, the lowest point in the last 10 years, according to a Deloitte report On the […]
7 February, 2020

SEFH joins the World Cancer Day recalling the importance of healthy habits and research

Source: www.immedicohospitalario.es The arrival of advanced therapies, such as CAR-T cells, immunotherapy or other targeted treatments and their incorporation into the assistance protocols are being able […]
6 February, 2020

Clinical research in Spain seeks new impulses to maintain its leadership position in Europe

Farmaindustria advocates strengthening the role of the Spanish Agency for Medicines and Health Products (Aemps) to maintain the competitiveness of our country in biomedical R&D The […]
5 February, 2020

The pharmaceutical industry responds to the increased incidence of cancer: one in two clinical trials focuses on oncology

The impulse to biomedical research in this area allows disease control for longer, increases survival and improves the quality of life of patients The Spanish Agency […]
28 January, 2020

Clinical trials, cost savings for the system and innovative therapies for the patient

They are essential to demonstrate the safety of medicines, but they also represent a significant cost savings in the health centers where they are carried out. […]
16 January, 2020

The Economic and Social Council advises the Government to promote investment in R&D

Source: www.actasanitaria.es Farmaindustria has reported that the Economic and Social Council (CES), a consultative body of the Government in socio-economic and labor matters, published a comprehensive […]
13 January, 2020

2019, a new year of “progress” and “remarkable progress” for pharmaceutical innovation

The European agency EMA gives green light to 30 new drugs and the US FDA, to 48 Hematology and oncology account for more than a third […]
10 January, 2020

The keys that can turn Spain into a reference for biomedical research

Source: www.20minutos.es Our country is one of the best conditions to host biomedical and pharmaceutical research projects, both national and international. In 1886, scientists Oskar Minkowski […]
8 January, 2020

The pharmaceutical industry accelerates against lung cancer, the one with the highest mortality in Spain

One in five clinical trials in Oncology in our country investigates this type of tumor, which causes 22,000 deaths per year The available treatments have tripled […]
Private zoneHoja de Validación
Reembolso de Gastos